Inventor
SCHADT OLIVER
DE58 patents
⚠️ This page may combine multiple inventors who share the name “SCHADT OLIVER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
29 patentsUS8367668B2Feb 5, 2013
Pyridazinone derivatives
MERCK PATENT GMBH9 citations84
US7572796B2Aug 11, 2009
Substituted indoles
MERCK PATENT GMBH13 citations84
US7566709B2Jul 28, 2009
1,3,4-Substituted pyrazoles as 5-HT receptor antagonists for the treatment of psychoses and neurological disorders
MERCK PATENT GMBH11 citations84
US7138417B2Nov 21, 2006
Inhibitors of integrin αvβ6
MERCK PATENT GMBH17 citations84
US7589112B2Sep 15, 2009
Methylene urea derivatives
MERCK PATENT GMBH9 citations83
US9062029B2Jun 23, 2015
Pyrimidinyl pyridazinone derivatives
MERCK PATENT GMBH3 citations74
US8859547B2Oct 14, 2014
Pyridazinone derivatives
MERCK PATENT GMBH4 citations73
US10669289B2Jun 2, 2020
Boronic acid derivatives
MERCK PATENT GMBH2 citations71
US10640520B2May 5, 2020
Boronic acid derivatives
MERCK PATENT GMBH2 citations71
US10294246B2May 21, 2019
Substituted boronic acids and boronate esters as immunoproteasome inhibitors
MERCK PATENT GMBH3 citations71
US10253049B2Apr 9, 2019
Boronic acid derivatives
MERCK PATENT GMBH2 citations71
US9308205B2Apr 12, 2016
Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyrdazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
MERCK PATENT GMBH3 citations71
US9403799B2Aug 2, 2016
Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase
MERCK PATENT GMBH1 citations63
US9376426B2Jun 28, 2016
Pyridazinone derivatives
MERCK PATENT GMBH2 citations63
US9284300B2Mar 15, 2016
Pyridazinone derivatives
MERCK PATENT GMBH1 citations63
US8927540B2Jan 6, 2015
Pyridazinone derivatives
MERCK PATENT GMBH1 citations63
US8921357B2Dec 30, 2014
Pyridazinone derivatives
MERCK PATENT GMBH1 citations63
US7960413B2Jun 14, 2011
Pyrazole compounds
MERCK PATENT GMBH6 citations63
US7816376B2Oct 19, 2010
Cyclic amides
MERCK PATENT GMBH5 citations63
US7534785B2May 19, 2009
3,6-dihydro-2-oxo-6H-1,3,4,-thiadiazine derivatives
MERCK PATENT GMBH2 citations63
US6645991B1Nov 11, 2003
αvβ3 integrin inhibitors
MERCK PATENT GMBH5 citations63
US11858951B2Jan 2, 2024
Boronic acid derivatives
MERCK PATENT GMBH0 citations62
US11274109B2Mar 15, 2022
Boronic acid derivatives
MERCK PATENT GMBH0 citations62
US9221806B2Dec 29, 2015
2-(heterocyclylbenzyl)pyridazinone derivatives
MERCK PATENT GMBH0 citations52
US7632951B2Dec 15, 2009
Inhibitors of integrin ανβ6
MERCK PATENT GMBH1 citations52
US9481668B2Nov 1, 2016
Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1
MERCK PATENT GMBH1 citations51
US9289427B2Mar 22, 2016
Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-hydrochloride salt and processes of manufacturing thereof
MERCK PATENT GMBH1 citations51
US7902186B2Mar 8, 2011
Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines
MERCK PATENT GMBH0 citations42
US7875644B2Jan 25, 2011
1-acyldihydropyrazole derivatives
MERCK PATENT GMBH0 citations42
DORSCH DIETER
10 patentsUS8580781B2Nov 12, 2013
Pyridazinone derivatives
DORSCH DIETER21 citations92
US8173653B2May 8, 2012
Pyridiazinone derivatives for the treatment of tumours
DORSCH DIETER21 citations84
US8853211B2Oct 7, 2014
Pyridazinone derivatives
DORSCH DIETER4 citations73
US8604036B2Dec 10, 2013
Pyridazinone derivatives
DORSCH DIETER5 citations73
US8557813B2Oct 15, 2013
2-benzylpyridazinone derivatives as met kinase inhibitors
DORSCH DIETER3 citations63
US8404685B2Mar 26, 2013
Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
DORSCH DIETER3 citations63
US8435981B2May 7, 2013
2-(heterocyclylbenzyl)pyridazinone derivatives
DORSCH DIETER0 citations52
US8623870B2Jan 7, 2014
Pyridazinone derivatives
DORSCH DIETER0 citations42
US8497266B2Jul 30, 2013
3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors
DORSCH DIETER0 citations42
US8426397B2Apr 23, 2013
3 (3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives
DORSCH DIETER0 citations42
SCHADT OLIVER
6 patentsUS8071593B2Dec 6, 2011
2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for the treatment of tumours
SCHADT OLIVER24 citations92
US8658643B2Feb 25, 2014
Pyrimidinyl pyridazinone derivatives
SCHADT OLIVER6 citations84
US8329692B2Dec 11, 2012
Pyrimidinyl pyridazinone derivatives
SCHADT OLIVER8 citations84
US8431572B2Apr 30, 2013
2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
SCHADT OLIVER2 citations62
US8058277B2Nov 15, 2011
Substituted indoles
SCHADT OLIVER0 citations51
US8158799B2Apr 17, 2012
Hydroxyquinoline derivatives
SCHADT OLIVER1 citations50
STIEBER FRANK
2 patentsBECKER AXEL
2 patentsUS8710058B2Apr 29, 2014
Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
BECKER AXEL4 citations69
US8586599B2Nov 19, 2013
Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
BECKER AXEL1 citations47
BUCHSTALLER HANS-PETER
1 patentShowing the top 50 of 58 patents by PatentIndex Score.